1. Home
  2. LEXX vs KPLT Comparison

LEXX vs KPLT Comparison

Compare LEXX & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • KPLT
  • Stock Information
  • Founded
  • LEXX 2004
  • KPLT 2012
  • Country
  • LEXX Canada
  • KPLT United States
  • Employees
  • LEXX 7
  • KPLT N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • KPLT Diversified Commercial Services
  • Sector
  • LEXX Health Care
  • KPLT Consumer Discretionary
  • Exchange
  • LEXX Nasdaq
  • KPLT Nasdaq
  • Market Cap
  • LEXX 38.9M
  • KPLT 33.2M
  • IPO Year
  • LEXX N/A
  • KPLT N/A
  • Fundamental
  • Price
  • LEXX $2.23
  • KPLT $5.92
  • Analyst Decision
  • LEXX Strong Buy
  • KPLT Hold
  • Analyst Count
  • LEXX 2
  • KPLT 2
  • Target Price
  • LEXX $11.00
  • KPLT $12.00
  • AVG Volume (30 Days)
  • LEXX 202.4K
  • KPLT 24.1K
  • Earning Date
  • LEXX 01-10-2025
  • KPLT 11-06-2024
  • Dividend Yield
  • LEXX N/A
  • KPLT N/A
  • EPS Growth
  • LEXX N/A
  • KPLT N/A
  • EPS
  • LEXX N/A
  • KPLT N/A
  • Revenue
  • LEXX $464,278.00
  • KPLT $241,789,000.00
  • Revenue This Year
  • LEXX $20.39
  • KPLT $12.92
  • Revenue Next Year
  • LEXX $113.25
  • KPLT $6.30
  • P/E Ratio
  • LEXX N/A
  • KPLT N/A
  • Revenue Growth
  • LEXX 105.24
  • KPLT 14.99
  • 52 Week Low
  • LEXX $1.20
  • KPLT $5.79
  • 52 Week High
  • LEXX $6.85
  • KPLT $23.54
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 47.23
  • KPLT 36.71
  • Support Level
  • LEXX $2.00
  • KPLT $6.09
  • Resistance Level
  • LEXX $2.54
  • KPLT $6.91
  • Average True Range (ATR)
  • LEXX 0.24
  • KPLT 0.48
  • MACD
  • LEXX -0.00
  • KPLT -0.01
  • Stochastic Oscillator
  • LEXX 27.06
  • KPLT 1.23

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About KPLT Katapult Holdings Inc.

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

Share on Social Networks: